Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Liabilities (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Total Liabilities for 16 consecutive years, with $55.9 million as the latest value for Q3 2025.

  • Quarterly Total Liabilities rose 5.23% to $55.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $55.9 million through Sep 2025, up 5.23% year-over-year, with the annual reading at $50.9 million for FY2024, 23.29% up from the prior year.
  • Total Liabilities for Q3 2025 was $55.9 million at Xtant Medical Holdings, up from $55.0 million in the prior quarter.
  • The five-year high for Total Liabilities was $55.9 million in Q3 2025, with the low at $23.2 million in Q3 2021.
  • Average Total Liabilities over 5 years is $37.0 million, with a median of $34.3 million recorded in 2023.
  • The sharpest move saw Total Liabilities crashed 74.38% in 2021, then soared 60.35% in 2023.
  • Over 5 years, Total Liabilities stood at $23.8 million in 2021, then grew by 9.45% to $26.1 million in 2022, then surged by 58.35% to $41.3 million in 2023, then increased by 23.29% to $50.9 million in 2024, then grew by 9.95% to $55.9 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $55.9 million, $55.0 million, and $52.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.